Vericel (VCEL) Interest Coverage Ratio (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -136.43% |
| Dec 31, 2025 | 533.67% |
| Sep 30, 2025 | 268.96% |
| Jun 30, 2025 | 84.54% |
| Mar 31, 2025 | -169.68% |
| Dec 31, 2024 | 849.66% |
| Sep 30, 2024 | 59.39% |
| Jun 30, 2024 | -10.38% |
| Mar 31, 2024 | -143.76% |
| Dec 31, 2023 | 342.07% |
| Sep 30, 2023 | 15.73% |
| Jun 30, 2023 | 29.06% |
| Mar 31, 2023 | -306.67% |
| Dec 31, 2022 | 142.21% |
| Sep 30, 2022 | 85.76% |
| Jun 30, 2022 | -12.39% |
| Mar 31, 2022 | -109.76% |
| Dec 31, 2021 | 183.47% |
| Sep 30, 2021 | -33.04% |
| Jun 30, 2021 | -12.83% |
| Mar 31, 2021 | -126.89% |
| Dec 31, 2020 | 598.83% |
| Sep 30, 2020 | 121.04% |
| Jun 30, 2020 | -229.31% |
| Mar 31, 2020 | -155.11% |
| Dec 31, 2019 | 197.38% |
| Sep 30, 2019 | 115.33% |
| Jun 30, 2019 | -501.55% |
| Mar 31, 2019 | -36,560.73% |
| Dec 31, 2018 | -57.69% |
| Sep 30, 2018 | 69.36% |
| Jun 30, 2018 | 5.27% |
| Mar 31, 2018 | -560.26% |
| Dec 31, 2017 | 88.08% |
| Sep 30, 2017 | -50.82% |
| Jun 30, 2017 | 77.04% |
| Mar 31, 2017 | -137.46% |
| Dec 31, 2016 | 79.15% |
| Sep 30, 2016 | 95.53% |
| Jun 30, 2016 | -150.20% |
| Mar 31, 2016 | 59.81% |
| Dec 31, 2015 | 32.24% |
| Sep 30, 2015 | -115.32% |
| Jun 30, 2015 | 50.46% |
| Mar 31, 2015 | -94.97% |
| Dec 31, 2014 | 85.38% |
| Sep 30, 2014 | -88.27% |
| Jun 30, 2014 | -83.47% |
| Mar 31, 2014 | 5.67% |
| Dec 31, 2013 | -102.86% |
| Sep 30, 2013 | 30.44% |
| Jun 30, 2013 | 26.95% |
| Mar 31, 2013 | 37.29% |
| Dec 31, 2012 | -83.87% |
| Sep 30, 2012 | 33.19% |
| Jun 30, 2012 | -8.67% |
| Mar 31, 2012 | -9.24% |
| Dec 31, 2011 | -5.31% |
| Sep 30, 2010 | -59.42% |